Delivery Order SPE2DB25D3005-SPE2DB25FQEYC
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$7.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,148.39, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,360,575 units of the prescription drug Jardiance 10 mg tablets. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,597,600 units of the prescription drug Jardiance 10 mg tablets. The contract has a ceiling value of $12,887.67 and an ultimate completion date of August 28, 2024. It is a firm-fixed-price contract, which means AmerisourceBergen will receive a predetermined amount for each unit delivered. This award is part of a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,065.03, is a delivery order for 4,568,033,522 units of the medication Jardiance 10 mg tablets. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery...
This federal contract award, valued at $4,653.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,986,149 units of the medication Jardiance 10 mg tablets, with an ultimate completion date of April 22, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $12,856.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets over a period ending on January 16, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. It is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, with ID SPE2DB20D3101|SPE2DB25FRGS9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,316.01 delivery order contract is for the supply of the prescription drug Jardiance 10 mg tablets. The contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $1,067.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,930,393 units of the diabetes medication Jardiance 10 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 17, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, with ID SPE2DB20D7059|SPE2DB24FQMJ8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jardiance 10 mg tablets. The contract has a firm fixed price of $1,151.42 and a completion date of September 10, 2024. Amerisourcebergen is the prime contractor, and there are no set-aside designations mentioned. This contract is likely part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,237.33, is for the delivery of Jardiance 10 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 3, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,454.92, is for the delivery of 4,567,886,502 units of the prescription drug Jardiance 10 mg tablet. The contract is a firm fixed-price delivery order with an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...